Measurement of antioxidant capacity using the biological antioxidant potential test and its role as a predictive marker of metabolic syndrome
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Oxidative stress increases the risk of cardiovascular complications of metabolic syndrome (MetS). This study was conducted to examine the difference in antioxidant capacity according to the presence of MetS, and to characterize the association between antioxidant capacity and MetS-related factors. Methods: We used the biological antioxidant potential (BAP) test to estimate antioxidant capacity. The BAP test has recently been used as an indicator of antioxidant capacity. We measured BAP levels in 45 patients with MetS (mean age, 44.6 ± 1.1 years) and 47 age- and sex-matched controls (mean age, 42.7 ± 1.1 years). To evaluate the association between antioxidant capacity and MetS, adiponectin, high-sensitivity C-reactive protein (hs-CRP), interleukin-6, tumor necrosis factor- α, and homeostatic model assessment for insulin resistance (HOMA-IR), linear regression and logistic analyses were performed. Results: The mean BAP of the MetS group (1,937.3 ± 36.5 μmol/L) was significantly lower than that of the non-MetS group (2,101.7 ± 29.5 μmol/L). Also, the mean BAP was low in persons having low high density lipoprotein and high triglyceride. Reduced antioxidant capacity was significantly associated with adiponectin, HOMA- IR and hs-CRP after adjusting for age and sex. The odds ratios for MetS with BAP, log adiponectin, log HOMA-IR, and log hs-CRP were 0.63 (95% confidence interval [CI], 0.49 to 0.82), 0.22 (0.10 to 0.51), 14.24 (4.35 to 46.58), and 1.93 (1.36 to 2.75), respectively. Conclusions: Persons with MetS showed reduced antioxidant capacity. We identified relationships between antioxidant capacity measured by BAP test and MetS, as well as MetS-related factors, such as insulin resistance, hs-CRP, and adiponectin.
Abstract
Background/Aims: Oxidative stress increases the risk of cardiovascular complications of metabolic syndrome (MetS). This study was conducted to examine the difference in antioxidant capacity according to the presence of MetS, and to characterize the association between antioxidant capacity and MetS-related factors. Methods: We used the biological antioxidant potential (BAP) test to estimate antioxidant capacity. The BAP test has recently been used as an indicator of antioxidant capacity. We measured BAP levels in 45 patients with MetS (mean age, 44.6 ± 1.1 years) and 47 age- and sex-matched controls (mean age, 42.7 ± 1.1 years). To evaluate the association between antioxidant capacity and MetS, adiponectin, high-sensitivity C-reactive protein (hs-CRP), interleukin-6, tumor necrosis factor- α, and homeostatic model assessment for insulin resistance (HOMA-IR), linear regression and logistic analyses were performed. Results: The mean BAP of the MetS group (1,937.3 ± 36.5 μmol/L) was significantly lower than that of the non-MetS group (2,101.7 ± 29.5 μmol/L). Also, the mean BAP was low in persons having low high density lipoprotein and high triglyceride. Reduced antioxidant capacity was significantly associated with adiponectin, HOMA- IR and hs-CRP after adjusting for age and sex. The odds ratios for MetS with BAP, log adiponectin, log HOMA-IR, and log hs-CRP were 0.63 (95% confidence interval [CI], 0.49 to 0.82), 0.22 (0.10 to 0.51), 14.24 (4.35 to 46.58), and 1.93 (1.36 to 2.75), respectively. Conclusions: Persons with MetS showed reduced antioxidant capacity. We identified relationships between antioxidant capacity measured by BAP test and MetS, as well as MetS-related factors, such as insulin resistance, hs-CRP, and adiponectin.
참고문헌 (32)
- Sharma P, "Oxidative stress in metabolic syndrome", Indian J Clin Biochem, 20, pp.145~149 (2005)
- Lim S, "Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007", Diabetes Care, 34, pp.1323~1328 (2011)
- 고경수, "인슐린저항성과 대사증후군", Diabetes and Metabolism Journal, 29(6), pp.511~516 (2005), 대한당뇨병학회
- Mohamed-Ali V, "Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo", J Clin Endocrinol Metab, 82, pp.4196~4200 (1997)
- Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance", Science, 259, pp.87~91 (1993)
- Baumann H, "The acute phase response", Immunol Today, 15, pp.74~80 (1994)
- Imperatore G, "Plasma fibrinogen: a new factor of the metabolic syndrome: a population-based study", Diabetes Care, 21, pp.649~654 (1998)
- Rifai N., "High-sensitivity C-reactive protein: a useful marker for cardiovascular disease risk prediction and the metabolic syndrome", Clin Chem, 51, pp.504~505 (2005)
- 이원영, "한국인 성인에서 대사증후군 및 인슐린 저항성에 따른 혈증 C-reactive protein 농도", 대한내과학회지, 64(2), pp.169~177 (2003), 대한내과학회
- Matsuzawa Y, "Adiponectin and metabolic syndrome", Arterioscler Thromb Vasc Biol, 24, pp.29~33 (2004)
- Schafer FQ, "Redox environment of the cell as viewed through the redox state of the glutathione disulfide", glutathione couple, 2001, pp.30, 1191~1212
- Reuter S, "Oxidative stress, inf lammation, and cancer: how are they linked?", Free Radic Biol Med, 49, pp.1603~1616 (2010)
- Roberts CK, "Oxidative stress and metabolic syndrome", Life Sci, 84, pp.705~712 (2009)
- Ford ES, "The metabolic syndrome and antioxidant concentrations:findings from the Third National Health and Nutrition Examination Survey", Diabetes, 52, pp.2346~2352 (2003)
- Furukawa S, "Increased oxidative stress in obesity and its impact on metabolic syndrome", J Clin Invest, 114, pp.1752~1761 (2004)
- Skalicky J, "Evaluation of oxidative stress and inflam-mation in obese adults with metabolic syndrome", Clin Chem Lab Med, 46, pp.499~505 (2008)
- 곽호경, "Relation of serum total antioxidant status with metabolic risk factors in Korean adults", Nutrition Research and Practice, 1(4), pp.335~340 (2007), 한국영양학회
- Eugenio LI, "Fundamental principles, signif icance and clinical application of oxidative stress assessment (d-ROMs, BAP and other Carratelli’s panel test)", Paper presented at: The 1st Korea Free Radicals and Antioxidants Seminar (2011)
- Lee SY, "Appropriate waist circumference cutoff points for central obesity in Korean adults", Diabetes Res Clin Pract, 75, pp.72~80 (2007)
- Vassalle C, "An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease", Clin Biochem, 41, pp.1162~1167 (2008)
- Hansel B, "Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity", J Clin Endocrinol Metab, 89, pp.4963~4971 (2004)
- Vekic J, "Oxidative stress, HDL and atherosclerosis", Antiinf lamm Antiallergy Agents Med Chem, 7, pp.158~165 (2008)
- Miri R, "Alterations in oxidative stress biomarkers associated with mild hyperlipidemia and smoking", Food Chem Toxicol, 50, pp.920~926 (2012)
- Abdilla N, "Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension", J Hum Hypertens, 21, pp.68~75 (2007)
- Chaves FJ, "Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension", Am J Hypertens, 20, pp.62~69 (2007)
- Ikebuchi M, "Effects of hyperglycemia on oxidative stress and antioxidant potential in patients with type 2 diabetes", Diabetol Int, 1, pp.72~77 (2010)
- Ridker PM, "Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?", Circulation, 109, pp.2818~2825 (2004)
- Bahceci M, "The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6and high sensitivity C-reactive protein levels: is adipocyte size associated with inflammation in adults?", J Endocrinol Invest, 30, pp.210~214 (2007)
- You T, "The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity", J Gerontol A Biol Sci Med Sci, 63, pp.414~419 (2008)
- Holvoet P, "Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome", JAMA, 299, pp.2287~2293 (2008)
- Katsuki A, "Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance", Diabetes Res Clin Pract, 73, pp.310~314 (2006)
- Vassalle C, "In vivo total antioxidant capacity: comparison of two different analytical methods", Clin Chem Lab Med, 42, pp.84~89 (2004)